Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACADEMIC: Alogliptin vs Acarbose in Chinese T2DM
NCT03794336Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alogliptin in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jun 2019; status: completed.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03794336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03794336.